Jardiance vs. Glimepiride
See how Jardiance and Glimepiride compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Jardiance is an SGLT2 inhibitor with proven heart and kidney benefits, while glimepiride is a sulfonylurea that only lowers blood sugar.
Glimepiride carries a higher risk of hypoglycemia on its own and costs far less per month than Jardiance.
Jardiance is approved for children 10 and older, heart failure, and chronic kidney disease, while glimepiride is approved only for adults with type 2 diabetes.
Jardiance vs. Glimepiride Drug Summary
Jardiance
Jardiance (empagliflozin) is an SGLT2 inhibitor that lowers blood sugar by causing the kidneys to remove excess glucose through urine. It is taken as a once-daily oral tablet and is also approved to reduce cardiovascular death, heart failure hospitalization, and chronic kidney disease progression.
Glimepiride
Glimepiride is a sulfonylurea that lowers blood sugar by stimulating the pancreas to release more insulin. It is taken as a once-daily oral tablet alongside diet and exercise, and is used only to treat type 2 diabetes in adults.
Jardiance vs. Glimepiride Side Effects
Jardiance
Glimepiride
Jardiance vs. Glimepiride Dosage
Jardiance
Glimepiride
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 25 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Jardiance
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 25 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Glimepiride
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Jardiance vs. Glimepiride Indications
Jardiance
Jardiance treats type 2 diabetes and also protects the heart and kidneys in people with related conditions. It is approved for adults and children 10 and older with type 2 diabetes, plus adults with heart failure or chronic kidney disease regardless of diabetes status.
Type 2 diabetes blood sugar control (ages 10+)
Reduces cardiovascular death in adults with type 2 diabetes and heart disease
Reduces hospitalization and death in heart failure, any ejection fraction
Slows progression of chronic kidney disease
Glimepiride
Glimepiride treats type 2 diabetes by helping the body release more of its own insulin. It is approved only for blood sugar control in adults, used alongside diet and exercise, with no additional approved use.
Type 2 diabetes blood sugar control in adults
Used alongside diet and exercise
Not approved for heart, kidney, or cardiovascular protection
Not approved for children
Jardiance vs. Glimepiride Pros and Cons
Jardiance
Jardiance offers proven heart and kidney protection beyond blood sugar control, making it a strong choice for patients with cardiovascular or renal risk. It costs significantly more than older generic options and carries some class-specific risks like ketoacidosis and genital infections.
Pros
Reduces risk of cardiovascular death and heart failure hospitalization
Slows chronic kidney disease progression
Approved for children 10 and older with type 2 diabetes
Lower hypoglycemia risk when used alone
Cons
Costs roughly $350 to $620 per month without insurance, before savings programs
Carries a risk of diabetic ketoacidosis, even with normal blood sugar
Can cause genital yeast infections and urinary tract infections
Not recommended for patients with significant kidney impairment
Glimepiride
Glimepiride is an inexpensive, well-established option for lowering blood sugar in type 2 diabetes. It lacks cardiovascular or kidney protective effects and carries a higher risk of hypoglycemia than newer drug classes.
Pros
Costs roughly $10 to $20 per month without insurance, before savings programs
Decades of clinical use with a well-understood safety profile
No risk of genital infections or diabetic ketoacidosis
Simple oral titration schedule
Cons
No proven cardiovascular or kidney benefit
Higher risk of hypoglycemia, especially in older adults
Associated with possible increased cardiovascular mortality (UGDP study)
Risk of hemolytic anemia in patients with G6PD deficiency
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.